adenovector based vaccine (Pascal Biosciences/University of British Columbia)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameadenovector based vaccine (Pascal Biosciences/University of British Columbia)
Drug Alias NameInfluenza A M1 vaccine (Pascal Biosciences/University of British Columbia)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionHLA-DR antigens-associated invariant chain agonists
TargetsHLA-DR antigens-associated invariant chain
Therapy Area/IndicationsInfluenza A virus infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNevis Brands Inc
China Registration ClassN/A

Develop Information

Active CompaniesNevis Brands IncThe University Of British Columbia
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A